LONDON (Reuters) - AstraZeneca
"This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials," AstraZeneca said in an emailed statement.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!